TickerFacts.

UL Solutions Inc. (ULS): Operating Cash Flow

Annual figures by period end, from SEC filings.

$600.00M
Year ended 2025-12-31
$678.00M
Trailing 12 months to 2026-06-30
+17.3%
3-year compound annual growth
2022-12-31: $372.00M2023-12-31: $467.00M2024-12-31: $524.00M2025-12-31: $600.00M$600.00M
2022-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$600.00M+14.5%2026-02-19, From 2025-01-01
2024-12-31$524.00M+12.2%2026-02-19, From 2024-01-01
2023-12-31$467.00M+25.5%2026-02-19, From 2023-01-01
2022-12-31$372.00Mn/a2025-02-20, From 2022-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Testing Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
UL Solutions Inc. (ULS)2025-12-31$600.00M+14.5%
NeoGenomics Inc (NEO)2025-12-31$5.23M-25.5%
20/20 Biolabs, Inc. (AIDX)2025-12-31-$1.92Mn/m
Hypha Labs, Inc. (FUNI)2025-09-30-$380.0Kn/m

Compare ULS, NEO, AIDX, FUNI side by side · Screen every company in Services-Testing Laboratories ↗